Clinical Trial Update: Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab plus capecitabine as first-line therapy for older patients with metastatic colorectal cancer; the study was terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-04